High Oral Carriage of Non-albicans Candida spp. among HIV-infected individuals

被引:31
|
作者
Mushi, Martha F. [1 ]
Mtemisika, Conjester I. [1 ]
Bader, Oliver [2 ]
Bii, Christine [3 ]
Mirambo, Mariam M. [1 ]
Gross, Uwe [2 ]
Mshana, Stephen E. [1 ]
机构
[1] Catholic Univ Heath & Allied Sci, Weill Bugando Sch Med, Dept Microbiol & Immunol, POB 1464, Mwanza, Tanzania
[2] Univ Med Ctr, Inst Med Microbiol, Kreuzbergring 57, D-37075 Gottingen, Germany
[3] Kenya Govt Med Res Ctr, Ctr Microbiol Res, POB 54840, Nairobi 00200, Kenya
关键词
Oral health; non-Candida albicans Candida spp; HIV; OROPHARYNGEAL CANDIDIASIS; COLONIZATION; FLUCONAZOLE; PREVALENCE; RESISTANCE; GLABRATA; CANCER;
D O I
10.1016/j.ijid.2016.07.001
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
Background: Non-albicans Candida (NAC) spp. in immunocompromised patients are linked to invasive infections with narrow treatment choice. This study aimed at comparing the oral colonization of NAC spp. between HIV and non-HIV infected individuals in Mwanza, Tanzania. Method: Oral rinse of 351 HIV-infected and 639 non-HIV infected individuals were collected between March and July 2015. Phenotypic identifications of Candida spp. was done using Candida Chromogenic agar and confirmed by MALDI-TOF MS. Results: NAC spp. were detected in 36/351 (10.3%) HIV-infected individuals compared to 28/639 (4.4%) of non-HIV infected individuals; P=0.0003. In HIV infected individuals, commonly isolated NAC spp. were Candida tropicalis, 10(2.8%), C. krusei (Issatschenki orientalis) 9(2.6%) and C. glabrata 8(2.3%). While for non-HIV infected individuals C. dubliniensis 8(1.3%) and C. tropicalis 5(0.9%) were commonly detected. As CD4 count/mu l decreases by one unit the risk of being colonized by NAC spp. among HIV infected individuals increases by 1% (OR 1.01, 95% CI; 1.001-1.004, P=0.001). Conclusion: The prevalence of NAC spp. is high among HIV-infected individuals with low CD4 count placing them at higher risk of invasive infections. Further studies to investigate the role of NAC spp. in causing invasive infections among immunocompromised patients are recommended. (C) 2016 The Author(s). Published by Elsevier Ltd on behalf of International Society for Infectious Diseases.
引用
收藏
页码:185 / 188
页数:4
相关论文
共 50 条
  • [21] In vitro activity of inexpensive topical alternatives against Candida spp. isolated from the oral cavity of HIV-infected patients
    Traboulsi, Rana S.
    Mukherjee, Pranab K.
    Ghannoum, Mahmoud A.
    INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 2008, 31 (03) : 272 - 276
  • [22] Dynamic analysis of oral Candida carriage, distribution, and antifungal susceptibility in HIV-infected patients during the first year of highly active antiretroviral therapy in Guangxi, China
    Jiang, Lanlan
    Yong, Xiangzhi
    Li, Runying
    Peng, Yuanyuan
    Liu, Wei
    Qin, Qi
    Zhang, Linlin
    Liu, Zhenmin
    Liang, Hao
    Tao, Renchuan
    JOURNAL OF ORAL PATHOLOGY & MEDICINE, 2014, 43 (09) : 696 - 703
  • [23] Fluconazole and voriconazole susceptibility in oral colonization isolates of Candida spp. in HIV patients
    Brito, Daniela
    Fernandez, Johelia
    Andrea Castillo, Maria
    Azuero, Sandra
    Hernandez-Valles, Rosaura
    Saul-Garcia, Yotsabeth
    Vizlero, Nereida
    Villalobos, Rafael
    Semprun-Hernandez, Neomar
    Martinez-Mendez, Dilia
    INVESTIGACION CLINICA, 2019, 60 (04): : 275 - 282
  • [24] Tuberculosis and non-tuberculous mycobacteria among HIV-infected individuals in Ghana
    Bjerrum, Stephanie
    Oliver-Commey, Joseph
    Kenu, Ernest
    Lartey, Margaret
    Newman, Mercy Jemima
    Addo, Kennedy Kwasi
    Hilleman, Doris
    Andersen, Aase Bengaard
    Johansen, Isik Somuncu
    TROPICAL MEDICINE & INTERNATIONAL HEALTH, 2016, 21 (09) : 1181 - 1190
  • [25] Influence of oral biofilm index, caries experience, and laboratory markers of disease progression on the oral carriage of Candida in HIV-infected and non-infected children: a cross-sectional study
    Melo de Brito Costa, Edja Maria
    de Almeida Maia, Carolina Medeiros
    Silva Vasconcelos, Priscilla Guimaraes
    Portela, Maristela Barbosa
    Barboza, Caroliny Mello
    Cardoso, Abel Silveira
    de Araujo Soares, Rosangela Maria
    Souza Dos Santos, Andre Luis
    BRAZILIAN JOURNAL OF MICROBIOLOGY, 2022, 53 (04) : 1969 - 1977
  • [26] Genetic diversity and antifungal susceptibility of Candida albicans isolates from Iranian HIV-infected patients with oral candidiasis
    Tamai, Iradj Ashrafi
    Pakbin, Babak
    Fasaei, Bahar Nayeri
    BMC RESEARCH NOTES, 2021, 14 (01)
  • [27] Increased serum and salivary immunoglobulins against Candida albicans in HIV-infected patients with oral candidiasis
    Drobacheff, C
    Millon, L
    Monod, M
    Piarroux, R
    Robinet, E
    Laurent, R
    Meillet, D
    CLINICAL CHEMISTRY AND LABORATORY MEDICINE, 2001, 39 (06) : 519 - 526
  • [28] Prevalence and antifungal drug sensitivity of non-albicans Candida in oral rinse samples of self-caring elderly
    Meurman, Jukka H.
    Parnanen, Pirjo
    Seneviratne, C. Jaya
    Samaranayake, Lakshman P.
    Saarinen, Antti M. J.
    Kari, Kirsti
    GERODONTOLOGY, 2011, 28 (04) : 246 - 252
  • [29] Antifungal susceptibility of non-albicans Candida spp. isolated from raw milk and human blood in Alborz and Tehran provinces
    Namvar, Zahra
    Sepahy, Abbas Akhavan
    Tabatabaei, Robab Rafiei
    Rezaie, Sassan
    IRANIAN JOURNAL OF MICROBIOLOGY, 2019, 11 (06) : 520 - 526
  • [30] Levels of salivary IgA antibodies to Candida spp. in HIV-infected adult patients: A systematic review
    Pomarico, Luciana
    Ribeiro de Souza, Ivete Pomarico
    Barbosa de Araujo Castro, Gloria Fernanda
    Teles, Ricardo Palmier
    Luiz, Ronir Raggio
    Maia, Lucianne Cople
    JOURNAL OF DENTISTRY, 2010, 38 (01) : 10 - 15